Precipio Inc (PRPO)
6.175
+0.32
(+5.38%)
USD |
NASDAQ |
Apr 25, 16:00
5.75
-0.42
(-6.88%)
After-Hours: 20:00
Precipio Cash from Financing (TTM): 1.742M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 1.742M |
September 30, 2023 | 1.72M |
June 30, 2023 | 1.843M |
March 31, 2023 | 0.131M |
December 31, 2022 | -0.225M |
September 30, 2022 | -0.175M |
June 30, 2022 | -0.252M |
March 31, 2022 | 15.10M |
December 31, 2021 | 16.24M |
September 30, 2021 | 18.32M |
June 30, 2021 | 22.65M |
March 31, 2021 | 9.231M |
December 31, 2020 | 9.338M |
September 30, 2020 | 8.67M |
June 30, 2020 | 7.035M |
March 31, 2020 | 9.042M |
December 31, 2019 | 9.663M |
September 30, 2019 | 10.50M |
June 30, 2019 | 9.211M |
March 31, 2019 | 7.599M |
December 31, 2018 | 6.811M |
September 30, 2018 | 7.057M |
June 30, 2018 | 8.695M |
March 31, 2018 | 7.809M |
December 31, 2017 | 7.102M |
Date | Value |
---|---|
September 30, 2017 | 5.01M |
June 30, 2017 | 2.135M |
March 31, 2017 | -0.645M |
December 31, 2016 | 0.775M |
September 30, 2016 | 0.475M |
June 30, 2016 | 2.393M |
March 31, 2016 | 3.426M |
December 31, 2015 | 8.991M |
September 30, 2015 | 12.07M |
June 30, 2015 | 10.04M |
March 31, 2015 | 13.29M |
December 31, 2014 | 10.07M |
September 30, 2014 | 6.907M |
June 30, 2014 | 5.366M |
March 31, 2014 | 3.773M |
December 31, 2013 | 7.37M |
September 30, 2013 | 6.136M |
June 30, 2013 | 7.566M |
March 31, 2013 | 4.923M |
December 31, 2012 | 14.60M |
September 30, 2012 | 18.45M |
June 30, 2012 | 18.39M |
March 31, 2012 | 19.38M |
December 31, 2011 | 1.726M |
September 30, 2011 | 4.975M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.252M
Minimum
Jun 2022
22.65M
Maximum
Jun 2021
7.883M
Average
9.042M
Median
Mar 2020
Cash from Financing (TTM) Benchmarks
Bruker Corp | -193.40M |
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |
Bionano Genomics Inc | 113.82M |
Akoya Biosciences Inc | 56.84M |